These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 1948121
1. National Cancer Institute study of luteinizing hormone-releasing hormone plus flutamide versus luteinizing hormone-releasing hormone plus placebo. Benson RC, Crawford ED, Eisenberger MA, McLeod DG, Spaulding JT, Dorr FA. Semin Oncol; 1991 Oct; 18(5 Suppl 6):9-12. PubMed ID: 1948121 [Abstract] [Full Text] [Related]
9. Leuprolide with and without flutamide in advanced prostate cancer. Crawford ED, Blumenstein BA, Goodman PJ, Davis MA, Eisenberger MA, McLeod DG, Spaulding JT, Benson R, Dorr FA. Cancer; 1990 Sep 01; 66(5 Suppl):1039-44. PubMed ID: 2118417 [Abstract] [Full Text] [Related]
10. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer. Labrie F, Dupont A, Giguère M, Borsanyi JP, Lacourciere Y, Bélanger A, Lachance R, Emond J, Monfette G. Prog Clin Biol Res; 1988 Sep 01; 260():41-62. PubMed ID: 3283766 [Abstract] [Full Text] [Related]
12. Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group. Schellhammer P, Sharifi R, Block N, Soloway M, Venner P, Patterson AL, Sarosdy M, Vogelzang N, Jones J, Kolvenbag G. Urology; 1996 Jan 01; 47(1A Suppl):54-60; discussion 80-4. PubMed ID: 8560679 [Abstract] [Full Text] [Related]
14. Total androgen blockade: the United States experience. Benson RC. Eur Urol; 1993 Jan 01; 24 Suppl 2():72-6. PubMed ID: 8262130 [Abstract] [Full Text] [Related]